Navigation Links
Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance
Date:4/28/2008

Food and Drug Administration (FDA) a supplemental regulatory

application for the additional use of the PROCLEIX ULTRIO assay to

screen donated blood for hepatitis B virus (HBV). The FDA approved the

assay to screen donated blood for HIV-1 and hepatitis C virus in late

2006. The Company is seeking approval to use the assay to screen for

HBV on both its semi-automated instrument platform and on the fully

automated, high-throughput TIGRIS system.

-- HPV Clinical Trial Begins. On March 31, Gen-Probe announced that the

Company had begun a pivotal U.S. clinical trial of its investigational

APTIMA assay to detect HPV, which causes cervical cancer. The

investigational APTIMA HPV assay is an amplified nucleic acid test that

is designed to detect 14 high-risk HPV types that are associated with

cervical cancer. More specifically, the assay is designed to detect two

messenger RNAs (mRNAs), E6 and E7, which are produced in higher amounts

when HPV infections progress toward cervical cancer. Gen-Probe expects

to enroll approximately 7,000 women in the study. Actual enrollment,

however, may vary based on the prevalence of cervical disease among

women in the trial. The trial enrollment and testing are expected to

take approximately two years.

-- Two PCA3 Studies Published. The leading peer-reviewed Journal of

Urology(R) published two important articles that the Company believes

illustrate the value of Gen-Probe's prostate cancer marker PCA3. In

the first article, "PCA3: A Molecular Urine Assay for Predicting

Prostate Biopsy Outcome" (Volume 179, Issue 4, Pages 1587-1592,

April 2008), researchers from the Urological Sciences Research

Foundation, The Johns Hopkins University, the University of Washington,

DiagnoCure and Gen-Probe conclude that PCA3 is
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Gen-Probe to Webcast Presentation at Morgan Stanley Global Healthcare Unplugged Conference
2. Gen-Probe to Webcast Presentations at Lehman and Cowen Healthcare Conferences
3. Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2007
4. Carl Hull Named President and Chief Operating Officer of Gen-Probe
5. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2007 Earnings Conference Call
6. Gen-Probe to Webcast Three Upcoming Presentations
7. Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues
8. Gen-Probe to Webcast Presentation at Bank of Americas 37th Annual Investment Conference
9. Simcere Pharmaceutical Group Reports Proposed Private Sale of Ordinary Shares by Existing Shareholder
10. CV Therapeutics Reports 2008 First Quarter Financial Results
11. Caliper Life Sciences Reports West Coast Consolidation of Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... bio-mimicking analog of one of nature,s most efficient ... team led by Alejandro Briseno of the University ... in developing long-sought polymer architecture to boost power-conversion ... electronic devices. , Briseno, with colleagues and ... Stanford University and Dresden University of Technology, Germany, ...
(Date:9/30/2014)... 30, 2014 Shimadzu Scientific Instruments ... easy-to-use and highly precise tool for measuring displacement ... elongation. With 1000-mm maximum movement distance, the DSES-1000 ... a gauge length of 10 mm. In addition, ... above 50-mm stroke and within +/- 100 µm ...
(Date:9/30/2014)... Proove Biosciences , the commercial and ... a new genetic test built upon research from their ... will provide physicians with an objective way to ... are stratified between individuals. With this new test, physicians ... a genetic predisposition that will affect their pain tolerance. ...
(Date:9/30/2014)... -- CORD:USE Cord Blood Bank – www.corduse.com ... into an Equity and Exclusive Services Agreement with Tianhe Stem ... patented technologies for the isolation of human cord blood-derived ... performing Phase I/II clinical trials in China ... Tianhe,s Stem Cell Educator Therapy showing that the therapy ...
Breaking Biology Technology:Blades of grass inspire advance in organic solar cells 2Blades of grass inspire advance in organic solar cells 3Shimadzu’s New Long-Travel Extensometer Increases Precision for Soft Material Testing 2Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 2Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 3CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 2CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 3CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 4
... number of US clinics, CHICAGO, IL, Sept. ... first commercially available bionic hand, today revealed details ... Assembly of the American,Orthotic and Prosthetic Association (AOPA). ... RACE Team and Partner Program are designed to ...
... 10 /Xinhua-PRNewswire-FirstCall/ -- Yongye Biotechnology,International, Inc. (OTC ... leading developer, producer and distributor of nutrients ... of China, today announced that it closed ... led by,Black River Asset Management, pursuant to ...
... Discovery of New Class of Anti-Inflammatory ... ... of The,Dr. Paul Janssen Award for Biomedical Research, Professor Marc Feldmann,FMedSci, FAA, ... Institute of Rheumatology, Imperial College London, are,being honored during a scientific symposium ...
Cached Biology Technology:Touch Bionics unveils innovative partner and reimbursement programs at AOPA 2Touch Bionics unveils innovative partner and reimbursement programs at AOPA 3Yongye Biotechnology International Raises $9.4 Million in Private Placement 2Yongye Biotechnology International Raises $9.4 Million in Private Placement 3Johnson & Johnson Honors 2008 Recipients of The Dr. Paul Janssen Award for Biomedical Research 2Johnson & Johnson Honors 2008 Recipients of The Dr. Paul Janssen Award for Biomedical Research 3Johnson & Johnson Honors 2008 Recipients of The Dr. Paul Janssen Award for Biomedical Research 4
(Date:9/30/2014)... conducted by the Ocean Health Index rates the ... overall health. In addition, for the first time, ... ocean regions beyond national jurisdiction (high-seas areas) ... safeguarding biodiversity and providing sustainable food sources. , ... a partnership led by scientists from UC Santa ...
(Date:9/30/2014)... team of environmental scientists and engineers, led by ... a three-year, $5.25 million grant from the U.S. ... Research to make a direct positive impact on ... and disposal of radioactive contaminants. , "Understanding the ... dealing with environmental aspects of nuclear technologies is ...
(Date:9/30/2014)... and farm runoff in Hawaii is causing tumors in ... The study, published Tuesday in the peer-reviewed open-access journal ... ends up in algae that the turtles eat, promoting ... and internal organs. , Scientists at Duke University, the ... Administration (NOAA) conducted the study to better understand the ...
Breaking Biology News(10 mins):Rating the planet's oceans 2Rating the planet's oceans 3Researchers get $5.25 million to advance nuclear technologies in South Carolina 2Pollution linked to lethal sea turtle tumors 2Pollution linked to lethal sea turtle tumors 3
... Keith and his team are working to efficiently capture the ... technology. In research conducted at the U of C, ... to reduce carbon dioxide (CO2) the main greenhouse gas ... simple machine that can capture the trace amount of CO2 ...
... The Fraser fir is gaining popularity among American ... favor Fraser fir for its conical shape, dark ... Consumer surveys indicate that the shape of ... Christmas tree selection, followed by needle retention, species, ...
... ARTICLE #1 FOR IMMEDIATE RELEASE Evidence that inexpensive ... Energy & Fuels Amid sticker-shock fuel prices, researchers ... tests verifying that a simple, inexpensive device attached to a ... to 20 percent. That translates into several more precious miles ...
Cached Biology News:Carbon dioxide 'scrubber' captures greenhouse gases 2Carbon dioxide 'scrubber' captures greenhouse gases 3Consumers influence christmas tree styles 2American Chemical Society's Weekly PressPac -- Sept. 24, 2008 2American Chemical Society's Weekly PressPac -- Sept. 24, 2008 3American Chemical Society's Weekly PressPac -- Sept. 24, 2008 4American Chemical Society's Weekly PressPac -- Sept. 24, 2008 5American Chemical Society's Weekly PressPac -- Sept. 24, 2008 6American Chemical Society's Weekly PressPac -- Sept. 24, 2008 7American Chemical Society's Weekly PressPac -- Sept. 24, 2008 8
... Lambda Protein Phosphatase ( ... protein phosphatase with activity ... and tyrosine residues. It ... product of the ORF221 ...
Angiotensin Converting Enzyme [Porcine Kidney, ACE, Peptidyl-dipeptidase A]...
Oven mesh sheets, large, 23 x 23cm, pack of 5...
Preparation Note: Prepared essentially by method of Singer, T.P., J. Biol. Chem., 174, 11 (1948). Quality Clarifier: Contains lipase Unit Definition: One unit will hydrolyze 1.0 μmole of p-ni...
Biology Products: